This goal of this study is to explore the effects of transcranial alternating current stimulation(tACS) combined with computerized cognitive training(CCT) on improving cognition for patients with mild cognitive impairment(MCI). The study will recruit 195 patients with MCI. Participants will undergo baseline cognitve assessment, EEG and structural and functional MRI. Participants will be randomized to active tACS+CCT group, sham tACS+CCT group and active tACS+sham CCT group. At the end of the intervention, 3-month, 6-month and 12-month follow-up, all subjects will repeat the baseline assessments.
tACS is a non-invasive brain stimulation technique that uses a low-intensity alternating current (1 to 2 mA) to apply a sinusoidal current to the scalp, directly interacting with the oscillating cortical activity at a given frequency with a given stimulus intensity. Studies have shown that simultaneous tACS on the left prefrontal lobe and left temporal lobe can significantly improve working memory in healthy older adults. The 40 Hz tACS is gamma oscillation, and more and more studies have pointed out that gamma oscillation regulation disorder is associated with impaired working memory function.CCT can improve the cognition in patients with MCI. We hypothesized that tACS combined with CCT can produce synergistic effects in sensitive brain areas.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
195
Transcranial alternate current stimulation (tACS) is a method of alternative current stimulation that can modulate neural activity by imposing local oscillatory activity.
Cognitive training includes memory, reasoning, processing speed and role playing, etc.
Shanghai Mental Health Center
Shanghai, Shanghai Municipality, China
Yangpu District Central Hospital
Shanghai, China
Change from baseline RBANS, Color Word Stroop Test (CWST),Visual Reasoning and Trails Making Task.
Global cognition will be assessed by the Repeatable Battery for the Assessment of Neuropsychological Status Total Score (RBANS).CWST mainly can examine the executive function. Visual Reasoning will be assessed by the Cambridge Mental Disorders of the Elderly Examination Visual Reasoning Test.Executive function will be assessed by Trails Making Task.
Time frame: up to 3 months(end of the intervention)
Neuroimage change from baseline Magnetic Resonance Imaging (MRI)
Including T1, resting state functional MRI, task based functional MRI and Diffusion Tensor Imaging(DTI)
Time frame: up to 3 months(end of the intervention)
changes in Gamma oscillation intensity (40-80 Hz) over DLPFC
measured by electroencephalogram (EEG)
Time frame: up to 3 months(end of the intervention)
Changes from baseline RBANS
Global cognition will be assessed by the Repeatable Battery for the Assessment of Neuropsychological Status Total Score (RBANS).
Time frame: 3 months after the end of the intervention,6 months after the end of the intervention and 12 month after the end of the intervention
Changes from baseline Color Word Stroop Test (CWST)
CWST mainly can examine the executive function. There are age-, sex-, and educational year-stratified norms; individuals' z-score can be calculated.
Time frame: 3 months after the end of the intervention,6 months after the end of the intervention and 12 month after the end of the intervention
Changes from baseline Visual Reasoning
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Visual Reasoning will be assessed by the Cambridge Mental Disorders of the Elderly Examination Visual Reasoning Test.
Time frame: 3 months after the end of the intervention,6 months after the end of the intervention and 12 month after the end of the intervention
Changes from baseline Trails Making Task
Executive function will be assessed by Trails Making Task.
Time frame: 3 months after the end of the intervention,6 months after the end of the intervention and 12 month after the end of the intervention
Changes from baseline Geriatric Depression Scale (GDS)
The Geriatric Depression Scale will be used to measure neuropsychiatric symptoms. It ranges from 0 to 30, and higher value represents a worse outcome.
Time frame: up to 3 months(end of the intervention),3 months after the end of the intervention,6 months after the end of the intervention and 12 month after the end of the intervention
Changes from baseline in Geriatric Anxiety Inventory (GAI)
Geriatric Anxiety Inventory (GAI) will be used to measure neuropsychiatric symptoms.
Time frame: up to 3 months(end of the intervention),3 months after the end of the intervention,6 months after the end of the intervention and 12 month after the end of the intervention
Neuroimage changes from baseline Magnetic Resonance Imaging (MRI)
Including T1, resting state functional MRI, task based functional MRI and Diffusion Tensor Imaging(DTI)
Time frame: 6 months after the end of the intervention and 12 month after the end of the intervention
Side-effects of tACS
Time frame: At each stimulation session,up to 3 months.